MedPage Today on MSN
Gene Therapy-Induced CAR T Cells for Myeloma Could Alter Treatment Landscape
ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...
Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...
Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T ...
Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...
A new type of CAR T-cell therapy elicits a more controlled immune response to cancer in mice, effectively killing cancer ...
The CAR T Vision Steering Committee has set an ambitious goal: to double the proportion of eligible patients treated with CAR T by 2030. 2 Reimbursement challenges stand out as an area where ...
Ever notice that as you get older, some foods no longer sit with you the same? This could be due to a breakdown of the ...
Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback